Form 4 for BMY Bristol Myers Squibb
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0000014272-22-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2021-12-31 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +47.4K | 131.7K | +56% | $0 |
| D | 2022-01-04 | 2021-12-31 | BMY | Elkins David V | EVP, CFO | F - Tax | $62.35 | -24.2K | 107.5K | -18% | -$1.51M |
| D | 2022-01-04 | 2021-12-31 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | -47.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2021-12-31 | M | A | 47,401 | $0.00 | 131,703 | D | — | — | (F1) In connection with the Merger, all outstanding Celgene Corporation Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2021, which is the end of the original performance period associated with the original Performance Share Unit award. |
| 2 | Common | Common Stock, $0.10 par value | 2021-12-31 | F | D | 24,246 | $62.35 | 107,457 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of awards. |
| 3 | Derivative | Restricted Stock Units | 2021-12-31 | M | D | 47,401 | $0.00 | 0 | D | — · — to 2021-12-31 | 47,401 Common Stock, $0.10 par value | (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F1) In connection with the Merger, all outstanding Celgene Corporation Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2021, which is the end of the original performance period associated with the original Performance Share Unit award. |